SGLT-2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A systematic review

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a common comorbidity with type 2 diabetes. The existing therapeutic options for NAFLD are not adequate. Hypocaloric diet and exercise is the cornerstone of therapy in NAFLD. Pioglitazone is the only drug recommended in diabetes patients with b...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:World J Diabetes
Main Authors: Raj, Henith, Durgia, Harsh, Palui, Rajan, Kamalanathan, Sadishkumar, Selvarajan, Sandhiya, Kar, Sitanshu Sekhar, Sahoo, Jayaprakash
Format: Artigo
Sprog:Inglês
Udgivet: Baishideng Publishing Group Inc 2019
Fag:
Systematic Reviews
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6379733/
https://ncbi.nlm.nih.gov/pubmed/30788048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4239/wjd.v10.i2.114
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker